UK markets closed

PTC Therapeutics, Inc. (PTCT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
37.20+0.07 (+0.19%)
At close: 04:00PM EDT
38.17 +0.97 (+2.61%)
After hours: 07:09PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
927,558
937,822
698,801
538,593
380,766
Cost of revenue
66,082
65,486
44,678
32,328
18,942
Gross profit
861,476
872,336
654,123
506,265
361,824
Operating expenses
Research development
587,568
666,563
651,496
540,684
477,643
Selling general and administrative
318,898
332,540
325,998
285,773
245,164
Total operating expenses
1,141,216
1,221,738
1,094,048
881,208
759,699
Operating income or loss
-279,740
-349,402
-439,925
-374,943
-397,875
Interest expense
142,683
129,180
90,871
86,022
56,352
Total other income/expenses net
-223,393
-217,528
-56,691
-57,375
51,295
Income before tax
-645,816
-696,110
-587,487
-518,340
-402,932
Income tax expense
-66,595
-69,506
-28,470
5,561
35,228
Income from continuing operations
-579,221
-626,604
-559,017
-523,901
-438,160
Net income
-579,221
-626,604
-559,017
-523,901
-438,160
Net income available to common shareholders
-579,221
-626,604
-559,017
-523,901
-438,160
Basic EPS
-8.67
-8.37
-7.79
-7.43
-6.64
Diluted EPS
-8.67
-8.37
-7.79
-7.43
-6.64
Basic average shares
74,131
74,838
71,729
70,466
66,028
Diluted average shares
74,131
74,838
71,729
70,466
66,028